Timothy Robey, C AI A
About Timothy Robey, C AI A
Timothy Robey is an Executive Director and Portfolio Manager at Eaton Vance, where he has worked since 2013. He is a two-time cancer survivor with a strong interest in cancer research and has extensive experience in fixed income investment strategies and ESG management.
Work at Eaton Vance
Timothy Robey has served as Executive Director and Portfolio Manager at Eaton Vance since 2013. In this role, he manages a diverse range of fixed income mandates, including Intermediate, Short Duration, Liquidity, Multi-Sector, Structured Credit, Investment Grade, High Yield, Global Credit, Credit Relative Value, Core+, and Core. His focus on fixed income strategies has contributed to the firm's investment offerings and client solutions.
Previous Experience in Asset Management
Before joining Eaton Vance, Timothy Robey held various positions in asset management. He worked as Vice President and Portfolio Manager at Lehman Brothers Asset Management and Neuberger Berman from 2003 to 2009. He also served as Senior Vice President and Portfolio Manager at Dwight Asset Management from 2009 to 2012. His early career included roles at Schwab Capital Markets as an intern and at Opus Investments as Assistant Portfolio Manager/Trader.
Education and Expertise
Timothy Robey holds a Master of Business Administration (MBA) in Asset Management from Yale School of Management, where he studied from 2019 to 2021. He also earned a Bachelor of Science (B.S.) in Finance from Bentley University, completing his studies from 1998 to 2001. Additionally, he has pursued further education at Boston University Graduate School of Management. His academic background supports his extensive experience in managing ESG investment strategies.
Interest in Cancer Research
Timothy Robey is actively interested in both for-profit and not-for-profit platforms that focus on breakthroughs in early cancer diagnoses and funding. As a two-time cancer survivor, he has a personal commitment to partnering with companies that are dedicated to cancer research and treatments. His experiences have shaped his passion for contributing to advancements in healthcare.